| 00:00 | Symposium: Lessons Learned about COVID-19 |
| 105.4 |
Immunogenetics (HLA and ABO) Lori Jeanne West, Canada |
| 105.6 |
Global Impact of COVID-19 on Transplantation Alexandre Loupy, France |
| 105.1 |
Virology, Epidemiology and Clinical Course Olivia S. Kates, United States |
| 105.2 |
Organ Specific Involvement of COVID-19 Aneesha Anand Shetty, United States |
| 105.3 |
Diagnostics: PCR, Antigen Detection and Serology Robin Patel, United States |
| 105.5 |
Therapeutics & Vaccines Michael G. Ison, United States |
| 00:00 | Symposium: Transplanting in the Era of COVID-19 |
| 110.2 |
When a Recipient with COVID-19 Can Proceed to Transplant Paolo Antonio Grossi, Italy |
| 110.1 |
Donor Screening and the Risk of Virus Transmission Thomas D. Mone, United States |
| 110.4 |
Transplantation in the Hot Zone Jean C. Emond, United States |
| 110.3 |
Lung Transplantation for COVID-19 Jingyu Chen, People's Republic of China |
| 110.5 |
Transplantation and Ethical Issues in the COVID Era: Doing the right thing depends on location, resources and disease burden Peter G. Stock, United States |
| 22:00 - 23:30 | Workshop Session: An Overview of Organ-Specific Transplantation in Children (diagnoses, procedures, outcome) |
|
Discussion and Q&A - -, |
| 202.2 |
Liver Winita Hardikar, Australia |
| 202.1 |
Kidney Katherine Twombley, United States |
| 202.3 |
Thoracic Jonathan Johnson, United States |
| 202.4 |
Pediatric Intestinal Transplantation George V. Mazariegos, United States |
| 23:30 - 00:15 | Oral Abstracts Session: Innate and Adaptive Immunity |
| 211.1 |
Gasdermin-D mutation is protective against renal ischemia reperfusion injury Jennifer Li, Australia |
| 211.5 (P-2.74 in Journal) |
Oral administration of nano-sized silicon particles attenuates oxidative stress and ischemia-reperfusion injury in a rat model: A novel hydrogen administration method Masataka Kawamura, Japan |
| 211.3 |
Modulation of the IL-33/ST2 axis for regulatory T cell therapy in transplantation Kento Kawai, United Kingdom |
| 211.4 |
Development of fully differentiated pancreatic organoids from hiPSCs for type 1 diabetes cell therapy Giuseppe Pettinato, United States |
| 00:15 - 02:00 | State-of-the-Art Session: Tissue-Resident Lymphocytes |
| 220.1 |
Formation and plasticity of tissue resident memory populations in human allografts revealed by single cell analysis and serial TCR sequencing Megan Sykes, United States |
| 220.2 |
Antigen presentation by tissue resident APC Adrian E. Morelli, United States |
| 220.3 |
Reshaping T cell memory with lymphoablation Anna Valujskikh, United States |
| 06:00 - 07:30 | Workshop Session: Intestinal Rehabilitation and Transplantation: A step in the future! |
| 242.2 |
Cost-efficiency of intestinal transplantation? Emilio Canovai, Belgium |
| 242.1 |
The role of glucagon-like Peptide-2 analogues in intestinal rehabilitation Palle Bekker Jeppesen, Denmark |
| 242.3 |
Living donation intestinal transplantation Taizo Hibi, Japan |
| 242.4 |
Fascia transplantation and pre-op embolization, novel techniques that change the field of intestinal transplantation? Irum I Amin, United Kingdom |
| 07:30 - 08:15 | Oral Abstracts Session: Kidney Transplantation: Underlying diseases and infections |
| 250.1 |
Cryptococcoma due to Cryptococcus albidus of a transplant kidney in a patient presenting with recurrent urinary tract infection: A clinical and metagenome sequencing study Ziyan Yan, People's Republic of China |
| 250.4 |
H1N1: A forgotten and mysterious entity in post renal transplant patients Sanshriti Chauhan, India |
| 250.3 |
DEEPGRAFT, a deep learning algorithm to classify kidney transplant diseases from digital whole slide biopsy images Jesper Kers, Netherlands |
| 250.2 |
Relationship between circulatory T follicular helper cells and CMV infection in kidney transplant recipients Patricia Suàrez-Fernández, Spain |
| 07:30 - 08:15 | Oral Abstracts Session: Immune Regulation and Outcomes |
| 251.2 |
Discovery of pMHC epitopes for directly alloreactive T cells Eric Taeyoung ES Son, Australia |
| 251.1 |
Elucidating the role of hypoxia in regulatory T cell function Marie Sion, United Kingdom |
| 251.3 |
The Prediction of Kidney Allograft Acute Rejection Based on Recipient Peripheral Blood Whole Transcriptome Profiling and Three mRNA Molecular Signatures Liao Minxue, People's Republic of China |
| 08:15 - 10:00 | State-of-the-Art Session: Managing Immunosuppression When Things Go Wrong |
| 261.1 |
Managing IS in recipients with a failing graft Sangho Lee, Korea |
| 261.3 |
Managing IS in recipients treated for malignancies Daniel Seron, Spain |
| 261.2 |
Managing IS in recipients with complex infections Peter Chin-Hong, United States |
| 08:15 - 10:00 | State-of-the-Art Session: Banff 2019 Update for Allograft Rejection |
| 262.1 |
Liver (morphology) Andrew Clouston, Australia |
| 262.4 |
Kidney (molecular) Carmen Lefaucheur, France |
| 262.3 |
Kidney (morphology) Hyeon Joo Jeong, Korea |
| 262.2 |
Liver (molecular phenotyping) Alberto Sanchez-Fueyo, United Kingdom |
| 14:30 - 15:15 | Oral Abstracts Session: Biomarkers and Omics |
| 281.3 |
Single cell transcriptomic analysis for a better understanding of human CD8+ regulatory T cells Céline Serazin, France |
| 281.1 |
Transplantation of older organs transfers senescence Jasper Iske, Germany |
| 281.5 (P-2.125 in Journal) |
TCR repertoire sequencing of total T cells and circulating follicular helper T cells in kidney transplant recipients Patricia Almendro Vázquez, Spain |
| 281.2 |
Diagnosis of kidney transplant rejection by tracking donor-reactive T-cell clones in the post-transplant biopsy, blood and urine samples Joseph R. Leventhal, United States |
| 15:15 - 17:00 | State-of-the-Art Session: Social Media for Scientists |
| 291.3 |
Impact of social media on research dissemination Carla C. Baan, Netherlands |
| 291.1 |
Introduction and creating networks Frank JMF Dor, United Kingdom |
| 291.2 |
Healthcare and patient education Macey L. Henderson, United States |
| 22:00 - 23:30 | Workshop Session: What the ID Doc should know about … |
| 302.4 |
Rejection in intestinal transplant Gabriel E. Gondolesi, Argentina |
| 302.1 |
CLAD Gregory I Snell, Australia |
| 302.2 |
Bilomas Prema Raj Jeyaraj, Singapore |
| 302.3 |
Delayed allograft function after renal transplant Roslyn B Mannon, United States |
| 23:30 - 00:15 | Oral Abstracts Session: Experimental and Preclinical Immunosuppression |
| 312.2 |
Targeting inflammatory monocytes by immune-modifying nanoparticles prevents acute kidney allograft rejection Christina Lai, Australia |
| 312.4 |
ABO self-tolerance in a mouse model: Evidence of tolerance at B cell but not T cell level Ibrahim Adam, Canada |
| 312.3 |
Carfilzomib and lulizumab-based desensitization prolongs allograft survival in sensitized non-human primates kidney transplantation model Jean Kwun, United States |
| 23:30 - 00:15 | Oral Abstracts Session: Advances in Liver and Intestinal Transplantation in Children |
| 313.2 |
Ionizing radiation exposure review in children with intestinal failure Ana c Grasso, Argentina |
| 313.4 |
Significance of sarcopenia in infants with pediatric liver transplantation for biliary atresia Masahiro Takeda, Japan |
| 313.1 |
Should steatotic livers be transplanted into pediatric recipients? Malcolm MacConmara, United States |
| 313.3 |
Marginal livers have excellent outcomes in pediatric patients with metabolic liver disease Christine Hwang, United States |
| 00:15 - 02:00 | State-of-the-Art Session: Timely Topics in Intestine and Multivisceral Transplantation |
| 322.2 |
Novel biomarkers and graft monitoring for ITx recipients Gabriel E. Gondolesi, Argentina |
| 322.1 |
DSA and AMR In ITx recipients: Monitoring, prevention, and treatment strategies Debra Sudan, United States |
| 322.3 |
Pediatric intestinal transplantation Cal Matsumoto, United States |
| 08:15 - 10:00 | State-of-the-Art Session: The Future is Now… Immune Regulation in Transplantation |
| 360.1 |
The Regulation of Immune Tolerance by FOXP3 - basic Ling Lu, People's Republic of China |
| 360.2 |
Intragraft immune regulation protects transplants under sub-therapeutic immunosuppression Paloma Riquelme, Germany |
| James Alexander Hutchinson, Germany |
| 360.3 |
Clinical experience of Treg therapy Fadi Issa, United Kingdom |
| 14:30 - 15:15 | Oral Abstracts Session: Immune Regulation and Tolerance I |
| 381.1 |
Treg use the PD-1-PD-L1 axis for lymphatic transendothelial migration Wenji Piao, United States |
| 381.2 |
Donor liver plasmacytoid dendritic cells promote effector T cell exhaustion and augment Treg responses in mouse spontaneous liver transplant tolerance Ryosuke Nakano, United States |
| 381.3 |
Lymph node stromal laminin alpha 5 regulates adaptive immunity Lushen Li, United States |
| 14:30 - 15:15 | Oral Abstracts Session: Anesthesia Management and Intestine Multivisceral |
| 383.4 |
Grafted colon in intestinal transplantation: Does it make a difference in patients outcome? Javier Serradilla, Spain |
| 383.3 |
Luminal preservation with a polyethylene glycol-based solution alleviates mucosal damage in human intestines John M Softeland, Sweden |
| 383.2 |
Impact of enhanced recovery after surgery (ERAS) protocols on robotic living kidney donor and recipient outcomes Amit Sharma, United States |
| 383.1 |
Continuous peri-operative regional analgesia by asymmetrical Erector Spinae Plane Blocks on live liver donors for liver resection: A cases serie retrospective analysis Viet Tuan Vu, Viet Nam |
| 00:15 - 02:00 | State-of-the-Art Session: WHO Designation 2020 ‘Year of the Nurse’: Scope of Work & Contributions made by Tx Nurses |
| 422.1 |
Psychosocial needs of living donors Dianne LaPointe Rudow, United States |
| 422.2 |
Nurse transplant coordinator roles in Japan Etsuko Soeda, Japan |
| 422.3 |
Nurse transplant coordinator roles in Korea Young-Jin Wang, Korea |
| 422.4 |
Nursing ethics in organ donation and transplantation Melanie M Robinson, Australia |
| 07:30 - 08:15 | Oral Abstracts Session: Organ Preservation and Reperfusion Injury / Repair |
| 452.1 |
Empagliflozin, a sodium-glucose cotransporter 2 inhibitor, improves donor heart recovery after prolonged cold storage in an isolated working rat heart model Jeanette E. Villanueva, Australia |
| 452.2 |
A single-centre, five-year experience with DCD heart transplantation Sarah E Scheuer, Australia |
| 452.3 (P-4.59 in Journal) |
NAPLES study (Normothermic machine perfusion of the liver to enable the sickest first): Preliminary results Hanns Lembach, United Kingdom |
| 452.4 |
Enhanced functional recovery of hearts donated after circulatory death (DCD) with ante-mortem heparin. Ling Gao, Australia |
| Poster Session: Intestine and Multivisceral Transplantation |
| P-10.03 |
More than 10 years of survival after intestinal transplant at a single center in Latin America, and its correlation with NOD2 mutations Maria V Gentilini, Argentina |
| P-10.04 |
Comparison of two novel formulas to predict parenteral nutrition discontinuation in adults with Type III intestinal failure Mariana Doeyo, Argentina |
| P-10.01 |
Surgical management of intestinal failure: Initial experiences from an intestinal failure, rehabilitation and transplant unit in Iran Hamed Nikoupour, Iran (Islamic Republic of) |
| P-10.02 |
A detailed analysis of the current status of intestinal transplantation in the Middle East Hamed Nikoupour, Iran (Islamic Republic of) |
| P-10.05 |
Long-term evolution of a medical-surgical unit for intestinal rehabilitation Alba Bueno, Spain |
